GB Sciences, Inc. (GBLX)
0.0002
0.00 (0.00%)
USD |
OTCM |
Sep 18, 16:00
GB Sciences Net Income (TTM)
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2024 | -1.043M |
| September 30, 2024 | -1.130M |
| June 30, 2024 | -1.374M |
| March 31, 2024 | -1.362M |
| December 31, 2023 | -3.760M |
| September 30, 2023 | -4.021M |
| June 30, 2023 | -3.900M |
| March 31, 2023 | -4.125M |
| December 31, 2022 | -4.868M |
| September 30, 2022 | 0.0988M |
| June 30, 2022 | -0.086M |
| March 31, 2022 | -0.1465M |
| December 31, 2021 | 3.373M |
| September 30, 2021 | -1.775M |
| June 30, 2021 | -2.201M |
| March 31, 2021 | -3.117M |
| December 31, 2020 | -6.654M |
| September 30, 2020 | -3.492M |
| June 30, 2020 | -4.063M |
| March 31, 2020 | -5.127M |
| December 31, 2019 | -6.219M |
| September 30, 2019 | -12.21M |
| June 30, 2019 | -19.92M |
| March 31, 2019 | -22.74M |
| December 31, 2018 | -27.91M |
| Date | Value |
|---|---|
| September 30, 2018 | -31.41M |
| June 30, 2018 | -25.39M |
| March 31, 2018 | -23.15M |
| December 31, 2017 | -15.87M |
| September 30, 2017 | -12.49M |
| June 30, 2017 | -11.82M |
| March 31, 2017 | -10.08M |
| December 31, 2016 | -9.163M |
| September 30, 2016 | -6.737M |
| June 30, 2016 | -6.936M |
| March 31, 2016 | -7.079M |
| December 31, 2015 | -9.402M |
| September 30, 2015 | -8.926M |
| June 30, 2015 | -8.001M |
| March 31, 2015 | -7.974M |
| December 31, 2014 | -4.658M |
| September 30, 2014 | -4.163M |
| June 30, 2014 | -2.109M |
| March 31, 2014 | -0.656M |
| December 31, 2013 | -0.3086M |
| September 30, 2013 | -0.0356M |
| June 30, 2013 | -0.3407M |
| March 31, 2013 | 0.0362M |
| December 31, 2012 | 0.8657M |
| September 30, 2012 | 0.7422M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Cocrystal Pharma, Inc. | -9.938M |
| CNBX Pharmaceuticals, Inc. | -0.4621M |
| Arvinas, Inc. | 9.30M |
| Fulcrum Therapeutics, Inc. | -85.00M |
| Definium Therapeutics, Inc. | -353.78M |